Water-soluble vidarabine derivatives alleviate catecholamine-induced heart failure and arrhythmia without impairing cardiac function in mice.
The worldwide standard guideline for treating heart failure (HF) is inhibition of the patients' chronically enhanced sympathetic nervous system activity. However, despite gains in the treatment of HF with angiotensin and β-adrenergic receptor (β-AR) blockers, some patients do not tolerate β-AR...
Saved in:
| Main Authors: | Kenji Suita, Yoshio Hayakawa, Yujiro Hoshino, Wenqian Cai, Reiko Kurotani, Yoshiki Ohnuki, Yasumasa Mototani, Yoshihiro Ishikawa, Satoshi Okumura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0330507 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice
by: Michinori Tsunoda, et al.
Published: (2023-08-01) -
Epac1 increases myosin regulatory light-chain phosphorylation, energetic cost of contraction, and susceptibility to heart failure.
by: Yoshiki Ohnuki, et al.
Published: (2025-01-01) -
Epac1 increases myosin regulatory light-chain phosphorylation, energetic cost of contraction, and susceptibility to heart failure
by: Yoshiki Ohnuki, et al.
Published: (2025-01-01) -
Allopurinol attenuates development of Porphyromonas gingivalis LPS-induced cardiomyopathy in mice.
by: Akinaka Morii, et al.
Published: (2025-01-01) -
THE PARTICIPATION OF CATECHOLAMINES IN THE PATHOGENESIS OF DIABETIC CARDIOMYOPATHY
by: Алексей Михайлович Чаулин, et al.
Published: (2020-03-01)